Coverage Policies

BCBS Northeastern New York

BCBS of Alabama

BCBS of Arizona

BCBS of Arkansas

BCBS of Florida (Florida Blue)

BCBS of Idaho

BCBS of Illinois

BCBS of Kansas

BCBS of Louisiana

BCBS of Massachusetts

BCBS of Michigan/Blue Card Network

BCBS of Minnesota

BCBS of Rhode Island

BCBS of Texas

BCBS of Western New York

BCBS of Wyoming

BS of California


Dean Health Plan by Medica

Excellus BCBS

Geisinger Health Plan

Harvard Pilgrim

Highmark BCBS of Delaware

Highmark BCBS of Pennsylvania

Highmark BCBS of West Virginia

Humana Medicare Advantage

Premera Blue Cross Alaska

Premera Blue Cross Washington

Regence Idaho

Regence Oregon

Regence Utah

UnitedHealthcare Commercial

UnitedHealthcare Medicare Advantage

WellMark BCBS Iowa

WellMark BCBS South Dakota


Local Coverage Determination (LCD): Biomarkers for Oncology (L35396)

ThyGeNEXT® and ThyraMIR® have been reviewed by the BlueCross BlueShield Association’s Evidence Street which found that clinical input from specialty societies and physicians at academic centers support use for individuals with nodule(s) with an indeterminate FNA finding…[testing] would provide a clinical meaningful improvement in net health outcome.
–From Medical Policy 2.04.78, Molecular Markers in Fine Needle Aspiration of the Thyroid